perifosine has been researched along with Medulloblastoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Becher, OJ; Cheung, NV; De Braganca, KC; Dunkel, IJ; Gilheeney, SW; Haque, S; Huse, JT; Khakoo, Y; Kolesar, JM; Kramer, K; Kushner, BH; Lyden, DC; Millard, NE; Modak, S; Spasojevic, I; Trippett, TM | 1 |
Broaddus, WC; Fillmore, HL; Kadian, R; Kumar, A; Tye, GW; Van Meter, TE | 1 |
1 trial(s) available for perifosine and Medulloblastoma
Article | Year |
---|---|
A phase I study of single-agent perifosine for recurrent or refractory pediatric CNS and solid tumors.
Topics: Adolescent; Antineoplastic Agents; Central Nervous System Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Ependymoma; Female; Glioma; Humans; Hyperuricemia; Male; Medulloblastoma; Neoplasm Recurrence, Local; Neuroblastoma; Neutropenia; Phosphorylcholine; Sarcoma, Ewing; Treatment Outcome; Wilms Tumor | 2017 |
1 other study(ies) available for perifosine and Medulloblastoma
Article | Year |
---|---|
The alkylphospholipid perifosine induces apoptosis and p21-mediated cell cycle arrest in medulloblastoma.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Survival; Cerebellar Neoplasms; Child; Cyclin-Dependent Kinase Inhibitor p21; Etoposide; Humans; Isoenzymes; Medulloblastoma; Phosphorylcholine; Proto-Oncogene Proteins c-akt; RNA, Small Interfering; Transfection | 2009 |